You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

21-122

Showing 1 - 25 of 8,193
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse B-Cell Lymphoma Trial in Worldwide (Avadomide (CC-122), Rituximab, Cyclophosphamide 750mg/m2 by IV infusion)

Completed
  • Diffuse B-Cell Lymphoma
  • Avadomide (CC-122)
  • +4 more
  • Washington, District of Columbia
  • +14 more
Apr 28, 2021

Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe Trial in Spain (OST-122, Placebo)

Completed
  • Ulcerative Colitis Chronic Moderate
  • Ulcerative Colitis Chronic Severe
  • Santiago de Compostela, A Coruña, Spain
  • +15 more
Jan 11, 2023

Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases Trial in Worldwide (LY3561774, Placebo)

Recruiting
  • Dyslipidemias
  • +3 more
  • Waterbury, Connecticut
  • +40 more
Aug 17, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Melanoma Trial in Tampa (CC-122, Nivolumab)

Completed
Has Results
  • Melanoma
  • Tampa, Florida
    H Lee Moffitt Cancer Center and Research Institute
Sep 27, 2022

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • (no location specified)
Jan 10, 2023

Primary Open-angle Glaucoma Trial in Bogotá, Zapopan (PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic)

Recruiting
  • Primary Open-angle Glaucoma
  • Bogotá, Bogotá D.C., Colombia
  • +1 more
Dec 22, 2021

Mental Health Wellness 1 Trial in Cali (The program comprises 12 sessions and additional activities to be carried out after each

Completed
  • Mental Health Wellness 1
  • The program comprises 12 sessions and additional activities to be carried out after each session, alongside counseling from the program's leading professionals
  • Cali, Valle Del Cauca, Colombia
    Arcadio de Jesús Cardona Isaza
Nov 9, 2023

Healthy Trial (Standard Process 21-Day Purification Program)

Not yet recruiting
  • Healthy
  • Standard Process 21-Day Purification Program
  • (no location specified)
May 24, 2023

Advanced Solid Malignancies Trial in Irving (GIM122)

Not yet recruiting
  • Advanced Solid Malignancies
  • Irving, Texas
    NEXT Dallas
Sep 8, 2023

Heart Failure With Reduced Ejection Fraction Trial (Survey)

Not yet recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Survey
  • (no location specified)
Nov 30, 2022

The Markers and Paracetamol Poisoning Study 2

Recruiting
  • Paracetamol Overdose
  • Surplus blood tests
  • Edinburgh, United Kingdom
    NHS Lothian
Sep 27, 2022

Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)

Recruiting
  • Prostate Cancer
  • PSMA-Targeted [In-111]-Labeled Trillium Compound
  • PTI-122
  • Glen Burnie, Maryland
  • +2 more
Mar 21, 2023

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in France, Italy, Netherlands (Obinutuzumab, CC-122)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Borddeaux Cedex, France
  • +9 more
Nov 11, 2022

Carcinoma, Hepatocellular Trial in Worldwide (CC-122, Nivolumab)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +13 more
Apr 16, 2021

Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))

Recruiting
  • Advanced Breast Cancer
  • +2 more
  • Trastuzumab Emtansine (T-DM1)
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023

Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)

Recruiting
  • Multiple Myeloma
  • TTI-622
  • Daratumumab Hyaluronidase-fihj
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)

Active, not recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Santa Barbara, California
  • +22 more
Jan 25, 2023

Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

Recruiting
  • Pemphigus Vulgaris
  • Pemphigus Foliaceus
  • efgartigimod PH20 SC
  • +2 more
  • Birmingham, Alabama
  • +130 more
Dec 22, 2022

Bipolar 1 Disorder Trial (Asenapine, Placebo)

Completed
Has Results
  • Bipolar 1 Disorder
  • (no location specified)
Feb 7, 2022

Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)

Not yet recruiting
  • Urothelial Bladder Carcinoma
  • Sacituzumab govitecan
  • +2 more
  • Santiago De Compostela, A Coruña, Spain
  • +9 more
Nov 14, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Thoracic Surgery, Atrial Fibrillation in High Risk Patients Trial in United States (Amiodarone, N-Acetylcysteine, Placebo)

Active, not recruiting
  • Thoracic Surgery
  • Atrial Fibrillation in High Risk Patients
  • Saint Louis, Missouri
  • +8 more
Mar 22, 2022

Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)

Not yet recruiting
  • Shigella Infection
  • Enterotoxigenic Escherichia Coli Infection
  • strain CVD 1208S-122
  • Placebo
  • Baltimore, Maryland
    University of Maryland, Baltimore, University of Maryland School
Jul 26, 2022